Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | Oxysterols receptor LXR-beta |
---|
Ligand | BDBM93875 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based dose response assay to identify agonists of the Liver-X-Receptor (LXR). |
---|
EC50 | 67541±n/a nM |
---|
Citation | PubChem, PC Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based dose response assay to identify agonists of the Liver-X-Receptor (LXR). PubChem Bioassay(2013)[AID] |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
Oxysterols receptor LXR-beta |
---|
Name: | Oxysterols receptor LXR-beta |
Synonyms: | LXRB | Liver X receptor beta (NR1H2) | Liver X, LXR beta | NER | NR1H2 | NR1H2_HUMAN | Nuclear receptor NER | UNR | Ubiquitously-expressed nuclear receptor |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 50978.79 |
Organism: | Homo sapiens (Human) |
Description: | P55055 |
Residue: | 460 |
Sequence: | MSSPTTSSLDTPLPGNGPPQPGAPSSSPTVKEEGPEPWPGGPDPDVPGTDEASSACSTDW
VIPDPEEEPERKRKKGPAPKMLGHELCRVCGDKASGFHYNVLSCEGCKGFFRRSVVRGGA
RRYACRGGGTCQMDAFMRRKCQQCRLRKCKEAGMREQCVLSEEQIRKKKIRKQQQESQSQ
SQSPVGPQGSSSSASGPGASPGGSEAGSQGSGEGEGVQLTAAQELMIQQLVAAQLQCNKR
SFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQI
ALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMR
RLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRM
LMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE
|
|
|
BDBM93875 |
---|
n/a |
---|
Name | BDBM93875 |
Synonyms: | (4-Phenyl-thiazol-2-yl)-pyridin-2-yl-amine | (4-phenylthiazol-2-yl)-(2-pyridyl)amine | 4-phenyl-N-(2-pyridinyl)-2-thiazolamine | 4-phenyl-N-pyridin-2-yl-1,3-thiazol-2-amine | MLS001206908 | SMR000524292 | cid_750531 |
Type | Small organic molecule |
Emp. Form. | C14H11N3S |
Mol. Mass. | 253.322 |
SMILES | N(c1nc(cs1)-c1ccccc1)c1ccccn1 |
Structure |
|